TG

Tamaghna Ghosh

Active Director Director DIN 10679120
DIN 10679120 First appointment Jun 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Tamaghna Ghosh

Data last updated:

Tamaghna Ghosh is a Director at Hetu Clinic Private Limited (since 2024). The company operates in Healthcare. Hetu Clinic Private Limited reported revenue of ₹1.6 Lakh (FY 2025).

DIN 10679120
Primary Designation Director
Industry Healthcare
First Appointment 24 Jun 2024
Oldest Company Age 2 yrs
Largest company Hetu Clinic Private Limited · ₹1.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hetu Clinic Private Limited U86900WB2024PTC271576
Director24 Jun 20242024₹1.6 Lakh (FY 2025)Active

Board colleagues of Tamaghna Ghosh

NameDINCompanyDesignation
Tamal Kanti Ghosh10679119Hetu Clinic Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hetu Clinic Private Limited
Premium access

Shareholding and investment profile for Tamaghna Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tamaghna Ghosh

Tamaghna Ghosh currently holds 1 directorship: Hetu Clinic Private Limited (Director, since 24 Jun 2024, revenue ₹1.6 Lakh (FY 2025)).

Tamaghna Ghosh was first appointed on 24 Jun 2024 as Director at Hetu Clinic Private Limited.

The current boards of Tamaghna Ghosh's companies include Tamal Kanti Ghosh (Hetu Clinic Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available